We are live on ! Find out more
FFTY icon

CapForce IBD 50 ETF

41 hedge funds and large institutions have $15.5M invested in CapForce IBD 50 ETF in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more call options, than puts

Call options by funds: $1.64M | Put options by funds: $432K

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

3% more funds holding

Funds holding: 4041 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

13.71% less ownership

Funds ownership: 33.81%20.1% (-14%)

47% less capital invested

Capital invested by funds: $29.2M → $15.5M (-$13.7M)

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
11
Reduced
9
Closed
12
Calls
$1.64M
Puts
$432K
Net Calls
+$1.21M
Net Calls Change
+$774K
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
1
BNP Paribas Financial Markets
France
$2.79M +$1.48M +40,174 +100%
LPL Financial
2
LPL Financial
California
$1.84M +$225K +6,098 +13%
IWM
3
IHT Wealth Management
Illinois
$1.66M +$5.6K +152 +0.3%
RWM
4
RMG Wealth Management
Wisconsin
$1.36M +$1.04M +28,151 New
CFP
5
Comprehensive Financial Planning
Pennsylvania
$1.04M -$653K -17,704 -37%
Bank of America
6
Bank of America
North Carolina
$753K +$82.1K +2,227 +11%
DSCM
7
Del-Sette Capital Management
New York
$731K -$17.4K -472 -2%
CPIG
8
Chicago Partners Investment Group
Illinois
$624K -$130K -3,522 -18%
Janney Montgomery Scott
9
Janney Montgomery Scott
Pennsylvania
$533K +$327K +8,857 +137%
HF
10
HRT Financial
New York
$507K +$538K +14,586 New
UBS Group
11
UBS Group
Switzerland
$472K +$371K +10,056 +286%
Cambridge Investment Research Advisors
12
Cambridge Investment Research Advisors
Iowa
$428K -$49.4K -1,339 -10%
TRCT
13
Tower Research Capital (TRC)
New York
$378K +$131K +3,556 +49%
PWM
14
Prosperity Wealth Management
California
$306K -$304K -8,252 -48%
MMA
15
Miracle Mile Advisors
California
$296K +$36.9K +1,000 +13%
Jane Street
16
Jane Street
New York
$282K +$298K +8,093 New
JP Morgan Chase
17
JP Morgan Chase
New York
$278K -$177K -4,811 -38%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$240K -$1.29M -35,104 -84%
Osaic Holdings
19
Osaic Holdings
Arizona
$218K -$172K -4,677 -43%
Citadel Advisors
20
Citadel Advisors
Florida
$216K +$229K +6,208 New
NA
21
NewEdge Advisors
Louisiana
$135K +$46.7K +1,266 +48%
KAS
22
Kestra Advisory Services
Texas
$72.1K +$76.4K +2,071 New
Simplex Trading
23
Simplex Trading
Illinois
$41.2K +$43.7K +1,184 New
Morgan Stanley
24
Morgan Stanley
New York
$35.8K +$4.9K +133 +15%
IAIM
25
International Assets Investment Management
Florida
$34.8K +$36.9K +1,000 New

FFTY Hedge Fund Activity: Q4 2025 in Review

41 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q4 2025, worth a combined $15.5M — down 47% from $29.2M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new FFTY positions and 12 closed out — a net gain of 1 holder — while 11 added to existing stakes and 9 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $1.48M. The largest seller was Synergy Asset Management, exiting entirely with an estimated $7.21M sold.

  • 41 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q4 2025, up from 40 in Q3 2025.
  • Funds reported $15.5M of CapForce IBD 50 ETF stock for Q4 2025, down 47% quarter-over-quarter.
  • 13 funds opened new CapForce IBD 50 ETF positions in Q4 2025 and 12 closed out, a net change of +1 holder.
  • The largest CapForce IBD 50 ETF buyer in Q4 2025 was BNP Paribas Financial Markets, an estimated $1.48M added.
  • The largest CapForce IBD 50 ETF seller in Q4 2025 was Synergy Asset Management, an estimated $7.21M sold.

Based on aggregated 13F filings for Q4 2025.